Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 34 |
| Jan 2026 | 0 | 21 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 01, 2018 Filed Jan 4, 2018 00:25 UTC |
GIVEN BRUCE DChief Operating Officer
|
GrantCommon Stock | 175,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001466 · doc4.xml · nonDerivative · entry 1 GIVEN BRUCE D · CIK 0001219384 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 948,356 F1 · shares: Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments. Read SEC document |
| January 01, 2018 Filed Jan 4, 2018 00:22 UTC |
Anzalone Christopher RichardDirector · Chief Executive Officer
|
GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001456 · doc4.xml · nonDerivative · entry 1 Anzalone Christopher Richard · CIK 0001423029 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,294,789 F1 · shares: Represents the maximum number of shares underlying a restricted stock unit that may be earned based on the achievement of four predetermined performance goals related to the advancement of the Company's clinical and preclinical programs and business development that must be achieved within three years. If the performance goals are not met within the required time periods, the award will be forfeited in part or in whole. F2 · balance_after: Includes a total of 1,838,000 shares underlying restricted stock units that may be earned based on the achievement of certain performance goals. If the performance goals are not met within the required time periods, the awards will be forfeited in part or in whole. Read SEC document |
| June 08, 2017 Filed Oct 6, 2017 20:14 UTC |
Myszkowski Kenneth AllenChief Financial Officer
|
GiftCommon Stock | 16,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-056291 · doc5.xml · nonDerivative · entry 1 Myszkowski Kenneth Allen · CIK 0001486672 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,023 F1 · balance_after: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions. Read SEC document |
| April 12, 2017 Filed Apr 14, 2017 20:07 UTC |
Anzalone Christopher RichardDirector · Chief Executive Officer
|
GrantCommon Stock | 978,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026974 · doc4.xml · nonDerivative · entry 1 Anzalone Christopher Richard · CIK 0001423029 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,794,789 F1 · shares: Represents the maximum number of shares underlying a restricted stock unit that may be earned based on the achievement of six predetermined performance goals related to the advancement of the Company's preclinical programs and business development that must be achieved within two years. If the performance goals are not met within the required time periods, the award will be forfeited in part or in whole. F2 · balance_after: Includes a total of 1,338,000 shares underlying restricted stock units that may be earned based on the achievement of certain performance goals. If the performance goals are not met within the required time periods, the awards will be forfeited in part or in whole. Read SEC document |
| January 01, 2017 Filed Jan 5, 2017 01:58 UTC |
Ferrari MauroDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001627 · doc4.xml · nonDerivative · entry 1 Ferrari Mauro · CIK 0001506045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,768 F1 · shares: Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date. Read SEC document |
| January 01, 2017 Filed Jan 5, 2017 01:52 UTC |
PERRY MICHAEL SDirector
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001622 · doc4.xml · nonDerivative · entry 1 PERRY MICHAEL S · CIK 0001250379 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,000 F1 · shares: Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date. Read SEC document |
| January 01, 2017 Filed Jan 5, 2017 01:56 UTC |
FRYKMAN EDWARD WDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001625 · doc4.xml · nonDerivative · entry 1 FRYKMAN EDWARD W · CIK 0001078202 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,852 F1 · shares: Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date. Read SEC document |
| January 01, 2017 Filed Jan 5, 2017 01:48 UTC |
GIVEN DOUGLAS BDirector
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001619 · doc4.xml · nonDerivative · entry 1 GIVEN DOUGLAS B · CIK 0001156207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · shares: Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date. Read SEC document |
| January 01, 2017 Filed Jan 5, 2017 01:44 UTC |
Leone Peter BrianVP, Strategy & Program Mgmt
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001617 · doc4.xml · nonDerivative · entry 1 Leone Peter Brian · CIK 0001635893 · VP, Strategy & Program Mgmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 F1 · shares: Represents shares underlying a restricted stock unit, which shares will vest in one installment in January 2019. Read SEC document |
| January 01, 2017 Filed Jan 5, 2017 01:41 UTC |
O'Brien PatrickGeneral Counsel
|
GrantCommon Stock | 145,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001612 · doc4.xml · nonDerivative · entry 1 O'Brien Patrick · CIK 0001627183 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 F1 · shares: Represents shares underlying a restricted stock unit, which shares will vest in one installment in January 2019. Read SEC document |
| January 01, 2017 Filed Jan 5, 2017 01:31 UTC |
Myszkowski Kenneth AllenChief Financial Officer
|
GrantCommon Stock | 145,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001607 · doc4.xml · nonDerivative · entry 1 Myszkowski Kenneth Allen · CIK 0001486672 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,689 F1 · shares: Represents shares underlying a restricted stock unit, which shares will vest in one installment in January 2019. Read SEC document |
| January 01, 2017 Filed Jan 5, 2017 01:27 UTC |
GIVEN BRUCE DChief Operating Officer
|
GrantCommon Stock | 380,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001605 · doc4.xml · nonDerivative · entry 1 GIVEN BRUCE D · CIK 0001219384 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 773,356 F1 · shares: Represents shares underlying a restricted stock unit, which shares will vest in one installment in January 2019. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 02:46 UTC |
Anzalone Christopher RichardDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 300,444 | $1.27 | $381,563.88 |
DisclosureSEC source: 0001209191-16-155526 · doc4.xml · nonDerivative · entry 1 Anzalone Christopher Richard · CIK 0001423029 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 816,789 F1 · kind: This disposition reflects the payment of tax liability by withholding shares incident to the vesting of restricted stock units previously granted. Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 23:53 UTC |
GIVEN DOUGLAS BDirector
|
SaleCommon Stock | 12,000 | $6.72 | $80,640.00 |
DisclosureSEC source: 0001209191-16-146247 · doc4.xml · nonDerivative · entry 2 GIVEN DOUGLAS B · CIK 0001156207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 F1 · balance_after: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions. Read SEC document |
| January 12, 2016 Filed Oct 18, 2016 23:53 UTC |
GIVEN DOUGLAS BDirector
|
GiftCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-146247 · doc4.xml · nonDerivative · entry 1 GIVEN DOUGLAS B · CIK 0001156207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,000 F1 · balance_after: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.